Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification and Characterization of Metabolic Dysfunction-Associated Steatotic Liver Disease Among Risk Groups in Turkey

NCT07548970 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT07548970
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07548970 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification and Characterization of Metabolic Dysfunction-Associated Steatotic Liver Disease Among Risk Groups in Turkey
Lead sponsor
Maastricht University Medical Center
Phase
Observational
Overall status
Completed
Start date
January 1, 2023
Completion date
December 31, 2024
Enrollment
459 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ferritin, hyperuricemia and mafld, lifestyle (sedentary behavior and physical activity), masld (metabolic dysfunction-associated steatotic liver disease), mediterranean diet, vitamin d deficiency